In wildtype males, binding of the MSL-1 gene product to the X chromosome is first seen at the cellular blastoderm stage (stage 5). MSL-2 is associated with the X chromosome in male embryos at a later stage, but the difference in apparent binding time between these two proteins is probably due to a difference in the sensitivity of their respective antisera. Early binding of MSL-1 is never seen in wildtype female embryos, and we have determined that this inhibition is mediated by the SXL product made by the activation of the early Sxl promoter. Once it is allowed to occur, the early X chromosome association of the MSLs is relatively stable, persisting in some cases through the first larval instar in spite of the presence of SXL levels concordant with normal female development. The results of these experiments are discussed in light of their relevance to the established observations that (1) the SXL made by the early promoter inhibits the hypertranscription of run at the blastoderm stage, and (2) severe disturbances in SXL function (loss in XX individuals and gain in haplo-X individuals) result in lethality during embryogenesis while loss of msl function kills males much later.
Introduction
In Drosophila, four gene products cooperate to enhance the transcription of most X-linked genes in males and, thereby, to compensate for the difference in gene dosage between the sexes (Belote and Lucchesi, 1980a,b; Breen and Lucchesi, 1986) . These four products, encoded, respectively, by the maleless (mle), male-specific lethal I (msl-1), male-specific lethal 2 (msl-2) and malespecific lethal 3 (msl-3) genes, collectively referred to as the msE genes, bind numerous sites along the X chromosome in male somatic tissues (Kuroda et al., 1991; Palmer et al., 1993; Hilfiker et al., 1994; Gorman et al., 1995; Kelley et al., 1995; Zhou et al., 1995) . The malespecific transcriptional enhancement of X-linked genes depends on the absence of active products from the Sexlethal (Sxl) gene, a conclusion based principally on the observation that a constitutive allele, SxP', causes malespecific lethality (Cline, 1978) and that partial loss-offunction alleles of Sxl lead to an abnormally high rate of transcription of both X chromosomes in mutant XX larvae (Lucchesi and Skripsky, 1981) . These mutant larvae are mosaics consisting of cells where SXL is expressed and cells where it is not. In the nuclei of cells lacking SXL, the MSL proteins associate with the two X chromosomes (Gorman et al., 1993; Hilfiker et al., 1994) .
Males carrying the constitutive allele SxlM1 die significantly earlier than msl mutant males (Cline, 1978; Belote and Lucchesi, 1980a) , although the cause of death in both cases is thought to be a failure of dosage compensation. Gergen (1987) used a dosage compensated hypomorphic allele of the X-linked segmentation gene runt (run) to test the effect of msl and Sxl mutations on dosage compensation during early development; he noted that the msl genes do not function at this time. SxlM1 also had no effect on the expression of the run allele in XY embryos. In contrast, loss-of-function mutations of Sxl were found to ameliorate the development of XX run embryos, leading 09254773/96/$15.00 0 1996 Elsevier Science Ireland Ltd. All rights reserved PII: SO925-4773(96)00517-S to the conclusion that both of their X chromosomes were hyperactivated by the dosage compensation mechanism.
The SxZ gene has two promoters. In female embryos, where the X:A ratio is equal to 1, the early promoter is activated leading to functional SXL products. These products are necessary to process the transcripts of the late or maintenance promoter so that more SXL proteins are generated and an autoregulatory maintenance loop is established. In male embryos, the early promoter is not activated; Sxl transcription is generated by the maintenance promoter but, in the absence of SXL protein, the transcripts are not processed to yield functional products (Bell et al., 1988; Salz et al., 1989; Bopp et al., 1991; Keyes et al., 1992) . In a recent paper, Bernstein and Cline (1994) have shown that the early SXL product, resulting from transcription driven by the early promoter, prevents the hyperactivation of the leaky mutant allele of run, i.e. it appears to control the dosage compensation of very early acting X-linked genes. The previously reported lack of effect of SxlM1 on the expression of run in male embryos could be ascribed to the fact that the constitutive expression of this allele occurs later in development.
Although the above considerations suggest that the msl gene products may not be needed until later development, the transcripts of at least one of these genes, m&l, are present in Northern blots of RNA extracted from all embryonic stages (Palmer et al., 1993) . Furthermore, mle, msl-I and msl-3 exhibit a slight maternal effect (Belote and Lucchesi, 1980) . It was of interest, therefore, to determine when during development, the MSLs first bind to the X chromosome in male embryos and to investigate the role that Sxl plays in preventing this association in females.
Results

Binding of MSL-1 in embryos
MSL-1 is first detectable in about half of the wildtype cellular blastoderm (stage 5) embryos examined (Table  1) . In these embryos, the protein is found within the nucleus of each somatic cell (with the exception of vitellophages), but not in the pole cells. In some embryos, a localized, brightly fluorescing mass is visible within a small subregion of each nucleus. This localized pattern is N, total number of embryos scored for a given classification, aEmbryo collections of mixed sex were derived from a wildtypc Samarkand strain (A), whereas embryo collections of almost exclusively one sex (B and C) were produced by utilizing the strains described in Walker et al. (1989) . bAt stage 7 of embryogenesis, MSL-1 is visually associated with the X chromosome of males and becomes diffuse in female.
observed in approximately half of all embryos that have entered late gastrulation (stage 7) or later developmental stages. In these embryos, the localized pattern is clearly associated with a single chromosome. Therefore, it is reasonable to conclude that the brightly fluorescing mass in the nuclei of earlier embryos also reflects the binding of MSL-1 to a single chromosome and that this chromosome is the X. These results are illustrated in Fig. 1 . To determine if this binding was indeed sex-specific, two types of homogametic males were employed to generate separate collections of XX or XY embryos (Walker et al., 1989) . In our hands, these males produced adult progenies consisting of 98.3% XX and 97.7% XY individuals, respectively. Examination of the two populations of embryos indicated that the initial appearance of MSL-1 in nuclei of blastoderm stage embryos occurred irrespective of gender; the localization over a small subregion of the chromosomes occurred, however, only in the male population (Table 1) .
To determine if the MSL-1 bound to the X chromosome in early embryos is of maternal origin, fertilized eggs of mixed chromosomal sex were collected from females homozygous for msl-l~269, an allele that contains a large deletion in the gene's open reading frame (Palmer et al., 1993) . We observed no difference between this group of embryos and those produced by wildtype mothers in the time during development when positive MSL-1 staining first appears (data not shown); this shows that binding of MSL-1 to the X chromosome in N, total number of embryos scored for a given classification. "Embryo collections of mixed sex were derived from a wildtype Samarkand strain (A), whereas embryo collections of almost exclusively one sex (B and C) were produced by utilizing the strains described in Walker et al. (1989). males can occur in the absence of maternal transcripts or protein.
MSL-I requires MSL-2 in order to become associated with the X chromosome
In salivary gland nuclei of third instar larvae, binding of MSL-1 to the X chromosome requires the presence of the wildtype products of the other msl genes (Gorman et al., 1993; Bone et al., 1994; Hilfiker et al, 1994; Gorman et al., 1995) . We wished to determine if the same relationship holds at the time when we can begin to detect MSL-1 binding in early embryos. To this end, we used a polyclonal antiserum against MSL-2. Female embryos never exhibit anti-MSL-2 staining ( Table 2) . Some of the XY embryos produced by homogametic fathers exhibit a staining pattern consisting of a localized, brightly fluorescing mass within a small subregion of the nuclei at the cellular blastoderm stage. As development proceeds, the percentage of embryos acquiring this staining pattern increases. However, in contrast to the results obtained with MSL-1, it is not until stage 1 I that all embryos display this pattern.
We wished to determine whether the difference in the developmental stage during which MSL-1 and MSL-2 are seen to bind to the X chromosome in male embryos is real or is the trivial result of a difference in the sensitivity of our antisera. We used daughterless (da) mutant mothers to increase the frequency of potentially positive embryos. Because of the well-documented fact that the product of the da gene must be present as a maternal contribution in the mature oocyte for the activation of the early Sxl promoter (Keyes et al., 1992) and subsequent SXL synthesis, all XX and all XY embryos produced by da females lack functional SXL proteins and, therefore, exhibit MSL binding to their X chromosomes (see below). We performed a cross that generated such embryos homozygous or heterozygous for an msl-2 mutation, in equal numbers. Only half of the embryos stained for MSL-1, and we conclude that MSL-1 will bind to the X chromosome only in the presence of MSL-2. Therefore, the difference in the time of binding of MSL-1 and MSL-2 is probably due to a difference in sensitivity of our antisera.
MSL-I binding is prevented in females by the SXL products derived from the activation of the early Sxl promoter
Chromosomally female zygotes from homozygous da' mothers raised at 25°C die as embryos since they cannot initiate a sufficient level of Sxl transcription; a substantial proportion of such embryos are rescued by the presence of a constitutive Sxl allele and develop into fertile females (Cline, 1978) . To investigate if the very early binding of MSL-1 that we observe in wildtype males is normally prevented from occurring in wildtype females by the initial burst of SXL synthesis, we collected embryos of both sexes produced from da1 mutant mothers. As can be seen in Table 3 , all embryos ascertained to be at stage 7 or older stained positively with MSL-1 antiserum and exhibited the characteristic subnuclear localization. These results show that the female embryos exhibit the male binding pattern, if transcription of Sxl gene products from the early promoter is prevented. This is indirect but conclusive evidence that SXL produced by the activity of the early promoter is necessary to prevent MSL association in females.
The association of MSL-I with the X chromosome is stable
To determine the stability of the association of MSL-1 with the X chromosome in XX embryos produced by da' mothers, we introduced the constitutive Sxl"' allele into their genotype. As mentioned above, the presence of the constitutive allele SxlM1 overcomes the lethal effects of the absence of DA and allows XX embryos to develop into adult females (Cline, 1978) . All embryos older than stage 7 exhibited binding of MSL-1 (Table 3) . Examination of first instar larvae revealed that in the majority of cases (n = 19 of 27) staining with MSL-1 antiserum was indistinguishable from that observed in wildtype male larvae of the same stage. Eight of the remaining larvae exhibited various levels of staining with some individuals having a much reduced level compared to males; nevertheless, these larvae still had detectable deposits of antibody localized over a region of each nucleus presumed to be the paired X chromosomes (Fig. 2) . One larva had no detectable association of the MSL-1 protein with the X chromosome. By third instar, female larvae were indistinguishable from wild type (data not shown).
Since SxlM1 males die in embryogenesis or in the first larval instar, we investigated whether MSL-1 is bound to the X chromosome in such individuals. Approximately half of the stage 7 and older embryos produced by homozygous SXP' mothers stained positively for the MSL-1 protein. These positive embryos must be XY, given that Table 3 Effects of SXL on MSL-1 binding bThe absence of maternally derived da product causes the lack of Sxl activation in female embryos (Cline, 1978) . Since males do not express SXL, all embryos are expected to lack SXL protein. 'Female embryos lacking activation of Sxl caused by the absence of da are rescued to adulthood by the constitutive expression of SXL protein by the SxP' allele. din this cross all embryos were constitutively expressing SXL protein due to the presence of Sxl"'. In contrast to females were the Sxl gene is activated by the regular mechanism, SXL protein is made relatively late in males (Bernstein and Cline, 1995) ; however, it is still expressed early enough to kill males in embryogenesis or first larval instar eAll four larvae examined were determined to be XY on the basis of the color of their mouth hooks, wildtype female embryos never exhibit anti-MSL-1 staining.
To determine if SxfM1 affects the stability of the binding in XY individuals, we examined first instar male larvae selected on the basis of a phenotypic marker. These larvae had a staining pattern that was indistinguishable from that of wildtype males (Table  3) . This indicates that the MSL-1 protein remains associated with the male X chromosome despite the presence of SXL produced from the activity of the maintenance promoter.
Discussion
Binding of MSL-I in early embryos requires the presence of MSL-2
In embryos, the msl-I gene must be activated very early since its product is present within the nuclei of either sex during the cellular blastoderm stage of development. This holds true both for embryos receiving a maternal contribution of msl-I gene products and for those embryos derived from homozygous mutant mothers, which have received neither msl-1 transcript nor protein. By late gastrulation (stage 7), the MSL-1 protein is bound to the X chromosome of all males. MSL-2 is also detected on the X chromosome in a small fraction of early cellular blastoderm embryos; in this case, though, the stage of development when all maies exhibit binding is stage 11. Given the dependence of each of the four MSLs on the presence of the other three in order to stably associate with the X chromosome in male larvae (Gorman, et al., 1993; Eone et al., 1994; Hilfiker et al., 1994; Gorman et al., 1995) , the differences in the stage during which binding is observed may be a reflection of differences in sensitivity of the polyclonal antisera used. By late gastrulation, MSL-2 may well be bound to the X chromosome in those embryos that exhibit MSL-1 staining but may not be detectable by its specific antiserum until its concentration reaches a critical threshold.
Our data confirm the report of Rastelli et al. (1995) that binding of MSL-1 and MSL-2 can be observed in stages 5-7. These authors noted that embryos lacking maternal MSL-1 components do not stain until stage 11. In contrast, we see no difference in time of detection of MSL-1 between such embryos and those produced by wildtype mothers. Once again, variations in antisera sensitivity can provide a plausible explanation for these differences. The apparent delay in binding of MLE in relation to the other MSLs that Rastelli et al. (1995) observe may be due to its presence at high levels, in both male and female embryos, resulting in an elevated background which could render the specific association of this gene product with the X chromosome unnoticeable until later in development.
The association of the MSLs with the X chromosome is relatively stable
XX embryos produced by da' mutant mothers exhibit MSL binding that persists to a significant extent, during early larval development, in spite of the presence of SxlM1 in their genome. Although only partially constitutive (Cline, 1980 (Cline, , 1984 Bernstein and Cline, 1995) , this particular SxZ allele produces a sufficient quantity of SXL products to rescue a large percentage of these larvae (Cline, 1978) . These observations suggest that the MSL complex associated with the X chromosome turns over and that its eventual disappearance, by the third larval instar, is the result of a depletion in one or more of its components mediated by the presence of active SXL products. Chromosome replication for cell division or polytenization would accelerate this process.
of Development 57 (1996) Although the binding of the MSLs to the X chromosome is negatively correlated to the function of the Sxl gene, the mechanism that restricts this binding to males was not understood. Recently, at least one of the keys to the sex-specificity of the MSLs has come to light: an intron, present in the 5' UTR of the msl-2 gene transcript, is spliced out in males and is retained in females (Bashaw and Baker, 1995; Zhou et al., 1995) . The presence of highly conserved putative SXL binding sites at both termini of this intron suggests that its excision is under Sxl control. Retention of the intron may be responsible for the very low steady-state level of msl-2 transcript in females. Additional putative SXL binding sites, present in the 5' UTR of the msl-2 transcript, have also been shown to play a role in MSL-2 regulation (Kelley et al., 1995) . It is reasonable to assume that these putative SXL binding sites are responsible for the absence of MSL-2 and, therefore, for the failure of the other MSLs to bind to the X chromosomes in female embryos.
Experimental procedures
Fly cultures and stocks
Drosophila stocks were maintained and crosses were performed at 25°C on standard cornmeal-molassesyeast agar medium containing propionic acid and methylparaben as mold inhibitors and seeded with active dry yeast.
The following stocks were used to obtain embryos of the desired genotypes by performing the appropriate crosses described in the table legends: Samarkand wild type; The expression of run in females is affected by mutations within the early promoter of Sxl but not by mutations that affect SXL production driven by the maintenance promoter (Bernstein and Cline, 1994) . Salz et al. (1989) have reported that the transient expression of the early promoter and the onset of expression of the maintenance promoter occur at approximately 2-4 h of development. We have demonstrated that MSL-1 and MSL-2 begin to associate with the X chromosome in XY embryos during cellular blastoderm, i.e. at approximately 2-3.5 h after fertilization.
Furthermore, this association is prevented from taking place in female embryos by the same regulatory mechanism that prevents the hypertranscription of the run gene. These results suggest one of the following two interpretations.
(1) Binding of the MSLs to the X chromosome in very young male embryos does not result in hyperactivation; only later in development, through the addition of some new component or through some activating mechanism, the MSLs exert their function. Such a possibility is suggested by the observation that the MSLs are associated with the two X chromosomes of females homozygous for a virilizer gene mutation (virtcF; Hilfiker and Nothiger, 1991) without any apparent effect on viability (Hilfiker et al., 1994) . (2) Binding of the MSLs to the X chromosome during embryonic development does, in fact, signal the onset of the MSLmediated dosage compensation.
If that were the case, the MSL-independent compensation of genes such as run and the MSL-mediated compensation of other early-acting Xlinked genes could either be separated by a very short developmental period or could occur simultaneously. The distinction between these possibilities necessitates quantitative activity measurements of several X-linked genes in A full description of the genetic markers used to characterize these stocks can be found in Lindsley and Zimm (1992) .
4.2, Embryo collection and processing
Embryos were collected by the method of Hildreth and Brunt (1962) and were treated as described by Karr and Alberts (1986) . The embryos were incubated for 1 h in a 1:500 dilution of primary antibody (polyclonal mouse or rabbit anti-MSL-1 or mouse anti-MSL-2). The secondary antiserum was preabsorbed goat anti-mouse or anti-rabbit conjugated to Cy3 or Cy5 (Jackson ImmunoResearch Laboratories); stock solutions (0.75 mg/ml in 50% glycerol) were diluted 1:500. The embryos were counterstained with DAPI (100 ng/@ PBS) for fluorescence microscopy; for confocal microscopy, chromomycin A3 was used if the secondary antiserum was conjugated to Cy3, and propidium iodide if the secondary antiserum was conjugated to Cy5. If propidium iodide was used, embryos were pretreated with RNase A prior to staining (Orsulic and Peifer, 1994) . Embryos were mounted in glycerol-propyl gallate solution (Kuroda et al., 1991) .
Embryos were staged according to the developmental schedule of Campos-Ortega and Hartenstein (1985) .
Processing ofjirst instar larvae
Larvae were bisected and treated as described for salivary gland chromosome preparations in Hilfiker et al. (1994) . Mouse anti-MSL-1 serum and Cy3-conjugated goat anti-mouse secondary antiserum (stock solution concentration of 0.75 mglml in 50% glycerol) were used at a concentration of 1500. The preparations were counterstained with Hoechst 33258 for DNA detection and were mounted as above.
